%0 Journal Article %T KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report %A Oi, Hajime %A Yoh, Kiyotaka %A Matsumoto, Shingo %A Izumi, Hiroki %A Shibata, Yuji %A Sakai, Tetsuya %A Nosaki, Kaname %A Zenke, Yoshitaka %A Goto, Koichi %J Precision Cancer Medicine %D 2022 %B 2022 %9 %! KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report %K %X %U https://pcm.amegroups.org/article/view/6869 %V 5 %P %@ 2617-2216